Angiogenesis in human gliomas: prognostic and therapeutic implications.

EXS

Volumn 79, Issue , 1997, Pages 29-46

  Johnson, J P ^a   Bruce, J N ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOHEXANE DERIVATIVE; ENDOTHELIAL CELL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FUMAGILLOL CHLOROACETYLCARBAMATE; LYMPHOKINE; O-(CHLOROACETYLCARBAMOYL)FUMAGILLOL; SESQUITERPENE; SURAMIN; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; BRAIN TUMOR; GLIOMA; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CYCLOHEXANES; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GLIOMA; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SESQUITERPENES; SURAMIN; TRANSFORMING GROWTH FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MLCS; MLOWN;

EID: 0030638744     PISSN: 1023294X     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-0348-9006-9_3     Document Type: Review

References (116)